Eric K. Steffe

Eric K. Steffe

Eric K. Steffe is a director in Sterne Kessler’s Biotechnology & Chemical Practice Group. Eric’s practice involves providing strategic counsel to his clients in various areas of patent law, with special emphasis on therapeutic antibodies, gene therapies, CRISPR, vaccines, diagnostics, antisense technologies, personalized medicine, and cell culturing/bioprocessing methods.


Posts by Eric K. Steffe


Can Process Confer Structure to Distinguish the Art after Biogen v. EMD Serono?

Courts have long held that "an old product made by a new process is not novel and cannot be patented." The validity of  product claims have generally …